Compare EBS & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EBS | CAL |
|---|---|---|
| Founded | 1998 | 1878 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 466.9M | 400.3M |
| IPO Year | 2006 | 1994 |
| Metric | EBS | CAL |
|---|---|---|
| Price | $8.10 | $10.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $12.00 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 614.2K | 521.4K |
| Earning Date | 04-30-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 2.13% |
| EPS Growth | ★ 125.83 | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $742,900,000.00 | $85,513,000.00 |
| Revenue This Year | $1.29 | $5.19 |
| Revenue Next Year | N/A | $2.45 |
| P/E Ratio | $116.79 | ★ N/A |
| Revenue Growth | N/A | ★ 0.46 |
| 52 Week Low | $5.62 | $8.80 |
| 52 Week High | $14.06 | $16.86 |
| Indicator | EBS | CAL |
|---|---|---|
| Relative Strength Index (RSI) | 43.90 | 37.00 |
| Support Level | $7.73 | $10.01 |
| Resistance Level | $8.95 | $13.97 |
| Average True Range (ATR) | 0.55 | 0.70 |
| MACD | -0.07 | -0.32 |
| Stochastic Oscillator | 27.17 | 12.78 |
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.